‘Protect each other’ – 215 new cases and one death as NPHET finalises vaccine strategy

‘It is important that we continue to protect each other.’
That’s the message from Chief Medical Officer Dr Tony Holohan after a further 215 cases of coronavirus were reported yesterday, with one additional death from the disease.
The government has approved NPHET’s advice on the prioritisation of COVID-19 vaccines, with a task force due to release a report on the rollout this Friday.
Adults aged over 65 who are in long-term care will be among the first to receive the vaccine in Ireland. Next up will be healthcare workers who work on the frontline and people aged over 70, with carers and people with medical conditions to be offered the vaccine, which will be free of charge, later.
While each of us awaits our opportunity to be vaccinated, it is important that we continue to protect each other in the meantime, particularly over Christmas and in the months ahead.
Avoid crowds, physically distance, wear face coverings, wash hands & follow public health advice
— Dr Tony Holohan (@CMOIreland) December 8, 2020
“This is an important step in the development of the vaccine strategy, being finalised by the High Level Taskforce for COVID-19 vaccination,” said Dr Holohan.
“While each of us awaits our opportunity to be vaccinated, it is important that we continue to protect each other in the meantime, particularly over Christmas and in the months ahead.”
“Continue to follow public health advice; avoid crowded places, physically distance, wear face coverings, wash hands regularly and practise cough/sneeze etiquette.”
Health Minister Stephen Donnelly said the vaccine developers are a “beacon of hope after a very difficult year”.
“Vaccination is a hugely effective intervention for saving lives and promoting good health.” said the minister.
“Of course, the safety and effectiveness of vaccines is our absolute priority and any COVID-19 vaccine administered in Ireland will have to be authorised by the European Medicines Agency. While we await news on whether these vaccines comply with all of the EMA’s requirements of quality, safety and efficacy, the government has been working ahead on plans for the roll-out of vaccines.”

